The anti-PD-L1 and rapamycin co-delivery system efficiently suppressed the tumor glycolysis metabolism, lactate release and M2-like TAMs polarization, as well as improving the immunosuppressive TME and tumor regression [131, 133]. This evidence concerns the gene CD274 and neoplasm.